Rama Burhan Hasan

Rama Burhan Hasan

Auto-generated profile, based on publicly available information

Rama Burhan Hasan

Department of Biomedical Science Faculty of Pharmacy, Omar Al‐Mukhtar University Al‐Bayda Libya

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in Food Science & Nutrition
Verified
Journal Article
Open access
AKAhmed Saeed Kabbashi
Ahmed Saeed Kabbashi
ZAZuhir S. Mussa Akrim
Zuhir S. Mussa Akrim
MSMohammed B. Suliman
Mohammed B. Suliman
SESanad Elhddad
Sanad Elhddad
AMAhmed Ali Mustafa
Ahmed Ali Mustafa
RHRama Burhan Hasan
Rama Burhan Hasan
The global escalation of antimicrobial resistance necessitates the exploration of plant‐based therapeutics with multi‐target mechanisms. This study provides a comprehensive evaluation of the Libyan Hibiscus sabdariffa L. calyx extract, encompassing phytochemical characterization, in vitro bioactivity, and in silico validation. Aqueous and ethanolic extracts were prepared and screened for antibacterial activity against clinically relevant multidrug‐resistant isolates (including determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)), antioxidant capacity via the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) radical assay, anti‐inflammatory effects by measuring their inhibition of albumin denaturation, and cytotoxicity using the brine shrimp lethality model. Gas Chromatography–Mass Spectrometry (GC–MS) analysis of the ethanolic extract revealed that the predominant fatty acid esters were oleic acid methyl ester (41.01%) and palmitic acid methyl ester (28.76%). Both extracts exhibited broad‐spectrum antibacterial activity, with MIC values ranging from 6.25 to 25 mg/mL and MBC/MIC ratios ≤ 2, confirming their bactericidal activity. The aqueous and ethanolic extracts showed superior efficacy against Pseudomonas aeruginosa (20.0 ± 1.73 mm inhibition zone; MIC: 6.25 mg/mL) and Staphylococcus aureus (20.0 ± 1.00 mm; MIC: 6.25 mg/mL), respectively. The antioxidant activities were comparable (IC 50 : 283.6 vs. 292.1 μg/mL). Remarkably, the aqueous extract demonstrated potent anti‐inflammatory activity (IC 50 : 129.81 μg/mL) and showed low preliminary toxicity in the brine shrimp lethality assay (LD 50 > 1000 μg/mL), whereas the ethanolic extract exhibited moderate toxicity (LD 50 : 345.5 μg/mL). Preliminary phytochemical screening of the aqueous extract revealed the presence of anthocyanins, flavonoids, tannins, phenolics, saponins, and reducing sugars, with a total phenolic content of 184.3 ± 5.2 mg GAE/g and a total flavonoid content of 92.7 ± 3.8 mg QE/g. Molecular docking showed that the identified compounds, such as linoleic acid methyl ester, exhibited strong binding affinities to bacterial DNA gyrase (up to −5.9 kcal/mol) and inflammatory targets, including COX‐2, 5‐LOX, and TNF‐α. ADMET predictions indicated favorable pharmacokinetic profiles for these compounds. These findings scientifically validate the traditional use of H. sabdariffa and highlight the potential of its aqueous extract as a promising source of bioactive compounds warranting further preclinical investigation for functional food and complementary health applications.

2 July 2026 in JSFA Reports
Verified
Journal Article
Open access
PDF file
AKAhmed Saeed Kabbashi
Ahmed Saeed Kabbashi
TSTaher Issa Shailabi
Taher Issa Shailabi
AKAhlam Mohamed Keshar
Ahlam Mohamed Keshar
AAAmel Mahmoud Abdrabo
Amel Mahmoud Abdrabo
AMAhmed Ali Mustafa
Ahmed Ali Mustafa
MIMaryam Mohammed Ibrahim
Maryam Mohammed Ibrahim
Background: The emergence of multidrug‐resistant bacteria necessitates the development of alternative therapeutic approaches. Thymus capitatus , a Mediterranean medicinal plant, has been traditionally used to treat various ailments, but its bioactive potential from Libyan origins remains underexplored. Results: The ethanol extract demonstrated superior bioactivity, significantly inhibiting S. aureus (37.3 ± 2.51 mm) and P. vulgaris (20.3 ± 0.75 mm). GC–MS analysis revealed 18 compounds, with thymol (35.07%) as the major constituent. The ethanolic extract showed potent bactericidal activity against S. aureus (MIC = 62.5 μg/mL, MBC = 125 μg/mL, MBC/MIC = 2). Both extracts exhibited concentration‐dependent anti‐inflammatory activity, with IC 50 values of 244.51 μg/mL (ethanolic) and 251.33 μg/mL (aqueous). The ethanolic extract showed substantial antioxidant potential (IC 50 = 189.4 ± 0.01 μg/mL), whereas both extracts were non‐toxic (LD 50 > 1000 μg/mL). Conclusion: These in vitro findings suggest that T. capitatus extracts possess significant therapeutic potential, supporting their traditional use. GC–MS confirmed thymol as the principal bioactive marker. However, further in vivo studies are necessary to validate these findings.